We had just finished up analyzing 2018 data from our HospiScope database and were also reviewing trends with non-communicable diseases in Latin America, all with the goal of updating our whitepaper — 5 Mega-Trends in Latin American Healthcare — for its 2019 edition.

As such, we decided to share some of the data we’ve collected. To add even more depth to our presentation, we welcomed some top healthcare experts to comment on our findings and offer their own analyses and perspectives, including:

Bill (Guillermo) García
Director Vertical Salud
Ricoh Latin America

Patricia Ocampo
Strategy and Business Transformation
Philips

Juan Carlos Rodríguez
COO and Supply Chain Director
Fundación Cardioinfantil

This expert panel was joined by GHI’s CEO, Guillaume Corpart, and our Director of Business Development and Intelligence, Mariana Romero Roy.

Click here to download the presentation slides.

If you’d like to request a copy of our 2019 Megatrends in Latin American Healthcare report, please click here.

We hope you find the webinar interesting, and please feel free to contact us with suggestions for future webinar topics or to explore more about how our unique services suite can help you spike your sales in the Latin American healthcare market.

This is why we created the infographic that you can download below.

Here you’ll find a number of key data points on the non-communicable diseases that are gaining ground in Latin America, such as diabetes, cancer, kidney disease, heart disease and dementia. You’ll also have numbers on a condition that may well be a factor in the development of some of these diseases — obesity — and much more, all designed to give you a quick reference resource that you can share with colleagues.

Explore More

While this data is helpful for everyday reference, making bigger decisions — a product launch, market entry, strategic planning and business development — all require deeper market intelligence.

And every day, we deliver this kind of market intelligence to healthcare, pharmaceutical and medical device/equipment manufacturers operating in Latin America. We go beyond simple data to apply strategic analysis that in turn points the way for your company’s next steps.

Contact us to find out more how our strategic understanding of Latin American healthcare can drive your future initiatives and maximize ROI.

Section 1 of the infographic focuses on the rapidly growing Latin American medical equipment market data, with numbers showing impressive gains in different product categories, including dialysis equipment, cardiac assist devices, endoscopy equipment and more.

Section 2 of the infographic shows how specific Latin American hospital markets are posting big increases in equipment counts. This data comes from HospiScope, GHI’s enormous LatAm hospitals database. Growth areas include echocardiogram machine counts, EEG machines, nuclear medicine systems and more.
[mk_title_box color=»#71BF38″ highlight_color=»#71BF38″ highlight_opacity=»100″ size=»18″ line_height=»34″ font_weight=»inherit» margin_top=»0″ margin_bottom=»18″ font_family=»none» align=»left»]Download infographic[/mk_title_box]

Of course, this infographic features just a small part of data found in GHI’s new whitepaper, 5 Mega-Trends in Latin American Healthcare, which you can order here.

SPIKE SALES

While data is helpful to understand market conditions, the real value is in knowing how to use it to improve sales with a more targeted approach.

Contact GHI today for 15-minute demo of HospiScope that will show you how to turn detailed data into dozens of new sales opportunities.

We noticed this while conducting healthcare research projects for different companies, and this led to us create HospiScope to track information about Latin American hospitals, as well as ShareScope for market data and In-Scope for more specific market intelligence work.

Obviously this blog is one of the ways we used to start promoting a freer flow of information in what has been kind of a data desert, but lately we have been publishing even more complimentary resources about Latin America’s medical devices and equipment market, as well as LatAm’s healthcare system.

Since you may not have heard of all of them, we wanted to let you know about them and give you direct access to them in one place.

#1 Ranking of the Best-Equipped Hospitals in Latin America, 2017

Using HospiScope data, this list shows which hospitals offer the best infrastructure in several categories, including accommodating newborns, diagnostic imaging and cardiovascular health.

#2: Latin American Hospitals Infographic

Essential data about LatAm’s hospital ecosystem offered in a handy infographic for easy reference.

#3 Whitepaper: 5 Mega-Trends in Latin American Healthcare

A highly detailed 40-page whitepaper that not only tracks some huge changes that are impacting LatAm medical care but also highlights which medical equipment and device categories are growing the most in different hospital markets during 2017, such as Argentina, Brazil, Chile, Colombia, Costa Rica, Dominican Republic Guatemala, Mexico and Peru, among others.
Easy organization makes this a great reference resource for Latin American hospital administrators, marketing and sales teams for medical device/equipment manufacturers targeting Latin America and healthcare professionals.

#4 Infographic: Data Portrait of the Medical Equipment Market in Latin America

Organized in 3 main sections, this comprehensive (50+ data points) infographic offers 2017 import data on medical equipment/devices for all of LatAm, key numbers on 2017 imports in specific markets, equipment counts for key categories in LatAm and in large and small markets in the region, as well as technology penetration data.

#5 Report: 2018 Latin American Hospital Fact Sheets

Covering 14 countries, this report offers incisive at-a-glance breakdowns on hospital infrastructure for LatAm countries, penetration rates of installed equipment in different areas and numbers on IT infrastructure in Latin American hospitals.

WHAT’S NEXT

During the summer of 2018 GHI will release its 2018 ranking of the best-equipped hospitals in Latin America, as well as infographics on surgical procedures performed in the region’s hospitals, videos, and import data for 2018, among other resources to help professionals have a detailed understanding of Latin American healthcare resources.

En general, la Population Reference Bureau (Oficina de Referencia Poblacional) ha reportado que para 2030, los cuatro ENT que son prevalentes en Latinoamérica —enfermedades cardíacas, la mayoría de los cánceres, diabetes y enfermedades respiratorias crónicas— serán responsables de aproximadamente el 81% de todas las muertes en Latinoamérica y el Caribe.

A continuación, desglosamos cifras específicas que se han proyectado para algunas de estas afecciones en 2030.

N°1 Cáncer

El cáncer es un problema creciente en países a lo largo del mundo y Latinoamérica no se ha escapado de sus garras. Al unir los datos de todos los países en Sudamérica, Centroamérica y el Caribe, el total de todos los nuevos casos de cáncer era 1.1 millones en 2012. Entre algunos de los cánceres más comunes en Latinoamérica se encuentran cáncer de mama, cáncer de próstata, cáncer colorrectal y cáncer del pulmón.

Todo parece indicar que la prevalencia de esta enfermedad seguirá creciendo en 2030. Por ejemplo, se espera que ya para 2030, los índices generales de cáncer para Latinoamérica crecerán en un 72% entre los hombres y el índice de muertes debidas a cáncer quizás suba en un 78% para los hombres latinoamericanos en ese año. Esto quiere decir que en 2030 habrá más de 917,000 casos de cáncer entre los hombres latinoamericanos, con 557,000 muertes. Para las mujeres en Latinoamérica, se pronostica que en 2030 sus índices de cáncer aumentarán en 62%, con un incremento del 74% en su mortalidad debida a esta afección.

N°2 Demencia (lo cual incluye el mal de Alzheimer)

Una noticia positiva en cuanto al cuadro cada vez más complejo de la salud en América Latina es que la expectativa de vida está creciendo en general. Una estimación indica que la expectativa de vida actual para los latinoamericanos es 75 años. Pero lo que acompaña una población mayor es un incremento en ciertas ENT como el mal de Alzheimer y otros tipos de demencia.

Un reporte de Bupa calculó que 7.8 millones de personas viviendo en las Américas estaban sufriendo de demencia en 2010 y proyectó que para 2030 esta cantidad se duplicará para llegar a 14.8 millones de personas.

Pronósticos adicionales sugieren todavía más crecimiento para esta enfermedad. Un reporte sobre la demencia en la región —titulada Dementia in Latin America: Epidemiological Evidence and Implications for Public Policy— indicó que la cantidad de personas con demencia en América Latina aumentará de 7.8 millones en 2013 a más de 27 millones para 2050.

N°3 Obesidad

Desde hace años la obesidad ha sido un fuerte problema en los países latinoamericanos y se espera que seguirá empeorándose durante los próximos anos. Los índices de personas con sobrepeso y obesidad en Latinoamérica ya están entre los más altos del mundo. Y para 2030 se espera que más del 50% de todos los hombres latinoamericanos y más del 60% de las mujeres latinoamericanas tendrán sobrepeso o serán obesos.

N°4 Diabetes

En muchos casos, un efecto colateral desgraciado de la obesidad es padecer la diabetes, y esto parece ser una preocupación creciente en los próximos anos. Según la Organización Panamericana de la Salud y la Organización Mundial de la Salud, la cantidad de personas en Latinoamérica que padecen de diabetes debe de aumentar de unos 25 millones a unos 40 millones en 2030.

Más retos futuros

Por supuesto, estas cuatro afecciones distan mucho de ser los únicos retos de salud que enfrentarán los latinoamericanos —y a sus sistemas de cuidado de salud— en 2030. Si bien no se han publicado y divulgado proyecciones para todas estas enfermedades, es muy probable que varias afecciones que ahora están impactando a la población latinoamericana la seguirán impactando de manera significativa en 2030.

Una de estas es la cardiopatía. Aunque no hay una proyección publicada de la cantidad de personas que sufrirán de enfermedades cardíacas en Latinoamérica en 2030, se sabe que actualmente entre un 20% a un 40% de los latinoamericanos sufren de la presión arterial alta, uno de los factores principales de riesgo para sufrir cardiopatías, junto con el sobrepeso/obesidad que ya tratamos anteriormente.

Además, investigaciones recientes de Deloitte y Novartis indican que cuatro afecciones cardíacas (ataque al corazón, fallo cardíaco, fibrilación atrial e hipertensión) afectan a casi 90 millones de personas en América Latina: el 27.7% de la población. Asimismo, la carga económica de estas cuatro afecciones cardíacas sumó un total de US$30.9 mil millones en 2015.

Aparte de las enfermedades cardíacas, hay otras afecciones actualmente impactando a Latinoamérica que probablemente la impactarán todavía más en 2030, a pesar de la falta de proyecciones en cuando a incidencia en ese año. Estas incluyen enfermedad renal (LatAm tiene el índice de mortalidad más alto del mundo para la enfermedad renal crónica), la enfermedad de Parkinson y las afecciones respiratorias como la enfermedad pulmonar obstructiva crónica y el asma, el cual afecta hasta 1 de cada 3 niños en Perú y que es bastante prevalente en muchos países de la región.

Enfrentar el desafío

Mediante HospiScope —el cual registra datos importantes sobre los hospitales latinoamericanos— hemos notado incrementos significativos en las cantidades de equipos y dispositivos médicos en los hospitales latinoamericanos en años recientes, tanto entre 2016 y 2017 como entre 2015 y 2017. Hemos escrito sobre estos incrementos en otras notas, destacando los aumentos en países específicos, desde Costa Rica a Mexico y Argentina y más. Estos incrementos sugieren que los hospitales de la región están haciendo lo mejor que puedan para enfrentar los retos presentados por estas enfermedades al adquirir más equipos que ayudan a diagnosticar y tratarlas, tales como máquinas de hemodiálisis, equipos respiratorios, máquinas de endoscopia, escáneres TAC, bombas de infusión y mucho más.

Cubrimos el aumento en las cantidades de equipos en los hospitales latinoamericanos en nuestro nuevo whitepaper —5 Mega-Trends in Latin American Healthcare —, el cual será publicado a finales de marzo de 2018.

Para averiguar cómo se puede usar HospiScope para identificar oportunidades potenciales de ventas con hospitales específicos que están agregando tipos específicos de equipos, favor de contactarnos.

Overall, the Population Reference Bureau reported that the four major NCDs that are prevalent in Latin America—cardiovascular disease, most cancers, diabetes and chronic respiratory diseases—will account for about 81% of all deaths in Latin America and the Caribbean by 2030.
Below we break out specific projected numbers for some of these conditions for 2030.

#1 Cancer

Cancer is a growing concern in countries throughout the world, and Latin America is certainly not an exception. If you pool the data of all the countries in South America, Central America and the Caribbean, the total number of new cancer cases in 2012 was around 1.1 million. Some of the most common cancers include breast cancer, prostate cancer, colorectal cancer and lung cancer.

As these numbers are projected out to 2030, they’re estimated to grow even higher. For example, overall cancer rates for Latin America are expected to grow by 72% among men by 2030, and the cancer death rate may jump by 78% by that year. To put this in context, that equals out to more than 917,000 cases of cancer in 2030 among Latin American men, with more than 557,000 deaths. For women in Latin America, in 2030 cancer rates are expected to increase by 62%, with a 74% increase in mortality.

#2 Dementia (including Alzheimer’s Disease)

One good bit of news about overall health in Latin America is that life expectancy is increasing overall. One estimate puts the current life expectancy for Latin Americans at 75 years old. But with an older population comes an increase in certain non-communicable diseases such as Alzheimer’s and other forms of dementia.

A report from Bupa estimated that 7.8 million people in the Americas (North and South America, as well as the Caribbean) were suffering from dementia in 2010 and projected that this amount would double to 14.8 million by 2030.

And future projections suggest even more growth: in addition, the 2017 report Dementia in Latin America: Epidemiological Evidence and Implications for Public Policy indicated that the number of people in Latin America with dementia will rise from 7.8 million in 2013 to more than 27 million by 2050.

#3 Obesity

Obesity has been a struggle for a while now in Latin American countries, and those issues are only expected to increase in the coming years. Rates of overweight and obesity in Latin America are already some of the highest in the world. And by 2030, it’s projected that more than 50 percent of all Latin American males and 60 percent of females will be overweight or obese.

#4 Diabetes

One unfortunate side effect of obesity in many cases is the onset of diabetes, and this appears to be a growing concern in the years ahead, as well. According to PAHO/WHO, the number of people in Latin America that suffer from diabetes is expected to increase from 25 million to 40 million by 2030.

More Challenges Ahead

Of course, these four conditions are far from the only challenges that will face Latin Americans — and their healthcare systems — by 2030. While projections have not yet been widely published and disseminated for all of these conditions, a number of diseases that are impacting the Latin American population now are likely to impact it significantly in 2030.

One huge one would be heart disease. Though there’s no published projection of the amount of people who will suffer from heart disease in Latin America in 2030, it’s known that currently 20-40% of Latin Americas suffer from high blood pressure, one of the major risk factors for heart disease, along with overweight/obesity, which we’ve already covered above. In addition, recent research from Deloitte and Novartis indicated that the four heart conditions (heart attack, heart failure, atrial fibrillation and hypertension) affect nearly 90 million people in Latin America — 27.7% of the population. Moreover, the economic burden of these four heart conditions in LatAm totaled more than US$30.9 billion in 2015.

Besides heart disease, other conditions currently impacting LatAm that are likely to impact it further by 2030, despite the lack of projections for incidence in that year. These would include
kidney disease (LatAm has the highest death rate from chronic kidney disease in the world), Parkinson’s disease and respiratory conditions like chronic pulmonary obstructive disorder and asthma, which affects up to 1 in 3 children in Peru and is quite prevalent in many countries.

Rising to the Challenge

Through HospiScope, which tracks demographic data about Latin American hospitals, we’ve noticed significant increases in medical equipment and devices in Latin American hospitals in recent years, both from 2016 to 2017 and between 2015 and 2017. We’ve written about some of these increases in other articles, covering specific countries. This suggests that Latin American hospitals are doing their best to meet the challenge from these illness by acquiring more equipment that helps diagnose and treat these conditions, such as hemodialysis machines, respiratory equipment, endoscopy machines, CT scanners, infusion pumps and much more.

We cover the increase in equipment counts in Latin American hospitals our new whitepaper, 5 Mega-Trends in Latin American Healthcare, set to be published in late March of 2018.

To find out how you can use HospiScope to identify potential sales opportunities with specific hospitals that are adding specific types of equipment, please contact us.